DK302185A - 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling - Google Patents

2-amino-oxazoliner samt fremgangsmaade til deres fremstilling Download PDF

Info

Publication number
DK302185A
DK302185A DK302185A DK302185A DK302185A DK 302185 A DK302185 A DK 302185A DK 302185 A DK302185 A DK 302185A DK 302185 A DK302185 A DK 302185A DK 302185 A DK302185 A DK 302185A
Authority
DK
Denmark
Prior art keywords
radical
lower alkyl
hydrogen
equal
denotes
Prior art date
Application number
DK302185A
Other languages
Danish (da)
English (en)
Other versions
DK302185D0 (da
Original Assignee
Rolland Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolland Sa A filed Critical Rolland Sa A
Publication of DK302185D0 publication Critical patent/DK302185D0/da
Publication of DK302185A publication Critical patent/DK302185A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK302185A 1984-07-05 1985-07-03 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling DK302185A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH326384 1984-07-05

Publications (2)

Publication Number Publication Date
DK302185D0 DK302185D0 (da) 1985-07-03
DK302185A true DK302185A (da) 1986-01-06

Family

ID=4252197

Family Applications (1)

Application Number Title Priority Date Filing Date
DK302185A DK302185A (da) 1984-07-05 1985-07-03 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling

Country Status (14)

Country Link
EP (1) EP0167459B1 (de)
JP (1) JPS61155375A (de)
AT (1) ATE69222T1 (de)
AU (1) AU579872B2 (de)
CA (1) CA1258040A (de)
DD (1) DD240015A5 (de)
DE (1) DE3584584D1 (de)
DK (1) DK302185A (de)
ES (2) ES8700853A1 (de)
HU (1) HU193333B (de)
MA (1) MA20480A1 (de)
OA (1) OA08166A (de)
PL (1) PL254398A1 (de)
PT (1) PT80779B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632860A1 (fr) * 1988-06-21 1989-12-22 Rolland Sa A Nouveaux medicaments antidepresseurs et les compositions pharmaceutiques en renfermant
DE69524962T4 (de) * 1994-08-22 2003-08-28 Mitsubishi Pharma Corp., Osaka Benzolderivate und deren medizinische verwendung
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
PT1471054E (pt) 2002-01-11 2009-09-23 Daiichi Sankyo Co Ltd Derivado de aminoálcool ou derivado de ácido fosfónico e composição medicinal que os contém
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물
RU2473545C2 (ru) * 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
MX2009008465A (es) 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
ES2398017T3 (es) * 2008-02-18 2013-03-13 F. Hoffmann-La Roche Ag Derivados de 4,5-dihidro-oxazol-2-il-amina
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
CA2728480A1 (en) * 2008-07-24 2010-01-28 F. Hoffmann-La Roche Ag 4,5-dihydro-oxazol-2-yl derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
CR20180443A (es) 2016-03-17 2018-11-21 Hoffmann La Roche Derivado de morfolina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448M (fr) * 1963-02-27 1964-04-06 Mcneilab Inc Composé de la classe des 2-amino-5-aryl-oxazolines et compositions pharmaceutiques le contenant.
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
US4647557A (en) * 1982-12-28 1987-03-03 Gerard Moinet Novel heterocyclic derivatives bearing an amino radical, processes for their production and the pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES553058A0 (es) 1987-05-01
DE3584584D1 (de) 1991-12-12
MA20480A1 (fr) 1986-04-01
EP0167459B1 (de) 1991-11-06
ES8705364A1 (es) 1987-05-01
HU193333B (en) 1987-09-28
AU579872B2 (en) 1988-12-15
OA08166A (fr) 1987-03-31
EP0167459A2 (de) 1986-01-08
EP0167459A3 (en) 1987-02-25
ES8700853A1 (es) 1986-10-16
JPS61155375A (ja) 1986-07-15
ES544926A0 (es) 1986-10-16
PT80779B (fr) 1987-01-12
CA1258040A (fr) 1989-08-01
DK302185D0 (da) 1985-07-03
ATE69222T1 (de) 1991-11-15
PL254398A1 (en) 1986-06-17
HUT38918A (en) 1986-07-28
PT80779A (fr) 1985-08-01
DD240015A5 (de) 1986-10-15
AU4468185A (en) 1986-01-30

Similar Documents

Publication Publication Date Title
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
DK302185A (da) 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
FI885594A0 (fi) Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel.
FI892787A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
ES8801807A1 (es) Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
PE20000645A1 (es) Derivados de 3-(2-oxo-[1,3`]bipirrolidinil-3-ilidenmetil)-cefemos
DK160486C (da) N-(4-amino-2,2-diphenyl-butyl)- eller n-(3-amino-2,2-diphenyl-propyl) urinstofforbindelser, fremgangsmaade til fremstilling af disse, samt en farmaceutisk komposition
DE69925250D1 (de) Aktivatoren der kalium-kanäle
DK146585A (da) 1,2,4-thiadiziner, praeparater med indhold deraf samt fremgangsmaade til deres fremstilling
ES2159551T3 (es) Derivados de acido glutamico heterociclico condensado utilizados como agentes antiproliferativos.
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
GB1481948A (en) 2-(disubstituted-amino)-4-phenyl-imidazolines and their use in pharmaceutical compositions
TH5599EX (th) อนุพันธุ์ของคาร์บาโมอิลลอกซีไธโอฟีน
IL82122A0 (en) Stable injectable antiemetic compositions containing benzamide derivatives
ATE73801T1 (de) Heterocyclische oxophthalazinylessigsaeure.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AHB Application shelved due to non-payment